Facebook to Acquire Startup Valued at $1 Billion 
 

The social-media giant is buying Kustomer, which specializes in customer-service platforms and chatbots, as Facebook looks to promote its platforms as a way to do business.

 
DoorDash Sets IPO Terms Pushing Valuation as High as $32 Billion 
 

DoorDash said it plans to sell 33 million shares in an initial public offering that could give the food-delivery company a valuation of as much as $32 billion.

 
S&P Global Agrees to Buy IHS Markit 
 

S&P Global has agreed to acquire IHS Markit for about $44 billion in a deal that would combine two of Wall Street's largest data providers.

 
NPC's Canceled Auctions Pave Way for Sale of Wendy's, Pizza Hut Chains to Flynn 
 

Wendy's has opposed the sale to Flynn, the largest restaurant franchisee in the U.S., and instead has made its own offer with a consortium of regional franchisees.

 
Moderna to Ask FDA to Authorize Vaccine 
 

The drugmaker is seeking authorization for its Covid-19 vaccine after it was shown to be 94.1% effective, keeping the shot on track to go into use in the U.S. by year's end, alongside Pfizer and BioNTech's.

 
Facebook, Google to Face New Antitrust Suits in U.S. 
 

Big Tech's legal woes are expected to worsen in the coming weeks as federal and state antitrust authorities prepare to file as many as four more cases targeting the tech giants by the end of January.

 
GM Won't Take Stake in Nikola 
 

The auto maker will no longer take an equity stake in the electric-truck maker under a stripped-down agreement, a significant retrenchment from an earlier pact that fueled investor enthusiasm for both companies.

 
Credit Suisse Spied on More Employees Than Previously Disclosed 
 

Lawyers hired by Credit Suisse in the aftermath of a spying scandal last year found two earlier instances of employees being followed by private investigators, despite the bank's assertions that it doesn't condone physical surveillance.

 
Kinaset Therapeutics Launches With $40 Million Series A to Advance Asthma Drug 
 

The biotech startup secured backing from 5AM Ventures, Atlas Venture and Gimv to develop a drug for people with severe asthma.

 
Airbnb, DoorDash Aim for Higher-Than-Expected Valuations 
 

Airbnb is planning to target a range of around $30 billion to $33 billion when the home-rental startup kicks off its investor roadshow. DoorDash, meanwhile, plans to target a range of around $25 billion to $28 billion.

 
 

(END) Dow Jones Newswires

November 30, 2020 15:15 ET (20:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.